Document ID: chunk:federal_register_of_legislation:F2024L01730:schedule:1:p28
Version: federal_register_of_legislation:F2024L01730
Segment Type: schedule
Provision Reference: sch 1 (pt 28/30)
Character Range: 90734–96729

the column headed "Brand" (all instances): Cipla Bisoprolol
[153] Schedule 5, entries for Celecoxib
omit from the column headed "Brand" (all instances): NOUMED CELECOXIB
[154] Schedule 5, entries for Dimethyl fumarate
omit from the column headed "Brand" (all instances): Dimethyl Fumarate MSN
[155] Schedule 5, entries for Duloxetine
substitute:
Duloxetine  GRP-19918  Capsule 30 mg (as hydrochloride)  Oral  APO-Duloxetine
                                                               Duloxecor
                                                               Duloxetine Sandoz
                                                               Duloxetine Sandoz 30
                                                               DYTREX 30
                                                               Tixol 30
Duloxetine  GRP-19957  Capsule 60 mg (as hydrochloride)  Oral  APO-Duloxetine
                                                               Duloxecor
                                                               Duloxetine Sandoz
                                                               Duloxetine Sandoz 60
                                                               DYTREX 60
                                                               Tixol 60

[156] Schedule 5, entry for Erlotinib in the form Tablet 150 mg (as hydrochloride)
insert in the column headed "Brand" after entry for the Brand "Erlotinib APOTEX": ERLOTINIB ARX
[157] Schedule 5, entries for Escitalopram
omit from the column headed "Brand" (all instances): NOUMED ESCITALOPRAM
[158] Schedule 5, entry for Esomeprazole in the form Tablet (enteric coated) 40 mg (as magnesium trihydrate)
(a) omit from the column headed "Form": Tablet (enteric coated) 40 mg (as magnesium trihydrate) substitute: Tablet (enteric coated) 40 mg (as magnesium)
(b) omit from the column headed "Brand": Esomeprazole Mylan
[159] Schedule 5, entry for Esomeprazole in the form Tablet (enteric coated) 20 mg (as magnesium trihydrate)
(a) omit from the column headed "Form": Tablet (enteric coated) 20 mg (as magnesium trihydrate) substitute: Tablet (enteric coated) 20 mg (as magnesium)
(b) omit from the column headed "Brand": Esomeprazole Mylan
[160] Schedule 5, entry for Fingolimod
substitute:
Fingolimod  GRP-26766  Capsule 500 micrograms (as hydrochloride)  Oral  AKM Fingolimod
                                                                        Fingolimod Sandoz
                                                                        Fingolimod SUN
                                                                        Fingolimod-Teva
                                                                        Fynod
                                                                        Gilenya
                                                                        Pharmacor Fingolimod

[161] Schedule 5, entry for Fluoxetine
substitute:
Fluoxetine  GRP-24550  Capsule 20 mg (as hydrochloride)  Oral  APO-Fluoxetine
                                                               Blooms the Chemist Fluoxetine
                                                               FLUOTEX
                                                               Fluoxetine APOTEX
                                                               Fluoxetine generichealth
                                                               Fluoxetine Sandoz
                                                               Zactin

[162] Schedule 5, omit entry for Hypromellose
[163] Schedule 5, entries for Lamotrigine
substitute:
Lamotrigine  GRP-19640  Tablet 200 mg  Oral  APX-Lamotrigine
                                             Lamictal
                                             LAMITAN
                                             Lamotrigine GH
                                             LAMOTRIGINE-WGR
                                             Logem
                                             Reedos 200
                                             Sandoz Lamotrigine
Lamotrigine  GRP-19706  Tablet 100 mg  Oral  APX-Lamotrigine
                                             Lamictal
                                             LAMITAN
                                             Lamotrigine GH
                                             LAMOTRIGINE-WGR
                                             Logem
                                             Reedos 100
                                             Sandoz Lamotrigine
Lamotrigine  GRP-19758  Tablet 50 mg   Oral  APX-Lamotrigine
                                             Lamictal
                                             LAMITAN
                                             Lamotrigine GH
                                             LAMOTRIGINE-WGR
                                             Logem
                                             Reedos 50
                                             Sandoz Lamotrigine
Lamotrigine  GRP-19807  Tablet 25 mg   Oral  APX-Lamotrigine
                                             Lamictal
                                             LAMITAN
                                             Lamotrigine GH
                                             LAMOTRIGINE-WGR
                                             Logem
                                             Reedos 25
                                             Sandoz Lamotrigine

[164] Schedule 5, entry for Lansoprazole in the form Capsule 30 mg
omit from the column headed "Brand": NOUMED LANSOPRAZOLE
[165] Schedule 5, entry for Metformin in each of the forms: Tablet containing metformin hydrochloride 850 mg; Tablet containing metformin hydrochloride 500 mg; and Tablet containing metformin hydrochloride 1g
omit from the column headed "Brand": APX-Metformin substitute: APX-METFORMIN
[166] Schedule 5, entries for Metoprolol
omit from the column headed "Brand" (all instances): NOUMED METOPROLOL
[167] Schedule 5, entry for Mycophenolic acid in the form